Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The non-label dialysis regimens are separate GlobalRPh reference material, not manufacturer instructions. No renal-adjusted meningitis regimen is inferred.
Check source scope before reading a dose
Merrem IV - labeled renal guidance
Product / population
Meropenem (Merrem IV), adult IV use for labeled infections
Renal guidance: 2, adult patients with renal impairment
Limits that apply to these rows
The FDA label has insufficient information for hemodialysis or peritoneal dialysis. Separate institutional regimens carry their own assumptions.
Adult renal dosing in this source
CrCl (mL/min)
Fraction of usual indication dose
Interval
>50
Full
Every 8 hours
26-50
Full
Every 12 hours
10-25
Half
Every 12 hours
<10
Half
Every 24 hours
Read the retained text before reformatting
Start with the usual dose for the infection. CrCl >50: usual dose every 8 hours. At 26-50: usual dose every 12 hours. At 10-25: half the usual dose every 12 hours. Below 10: half the usual dose every 24 hours. The FDA label has insufficient information for hemodialysis or peritoneal dialysis. Separate institutional regimens carry their own assumptions.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.
